美國Cepheid  www.cepheid.com
總部位于美國加州Sunnyvale的美國Cepheid公司(納斯達克交易代碼:CPHD)是一個致力于研發(fā)、生產和應用的分子診斷廠家；是致力于在臨床、工業(yè)和生物威脅領域開發(fā)完全整合的快速、準確、便捷的檢測系統(tǒng)，例如：在臨床領域中的傳染病和癌癥的診斷，工業(yè)領域中食品、農業(yè)和環(huán)境的檢測，生物威脅領域中生物恐怖因子的鑒定識別。

China
Inno Health Co., Ltd. (Northeast China-exclusive in Heilongjiang, Jilin, and Liaoning and non-exclusive in Beijing)
Tel:
Email: inno.yide@gmail.com
 
天津儀美科技有限公司
Tianjin YiMei Science Co., Ltd.
(North China-exclusive in Tianjin, Hebei, Shanxi and Inner Mongolia and non-exclusive in Beijing)
Tel:
Email: yimei@yimeisci.com 
Web: http://www.yimeisci.com
 
Shanghai MDx Co., Ltd.
(East China-exclusive in Shanghai, Jiangsu, Zhejiang, Shandong, Fujian, Anhui and Jiangxi)
Email: shanghaimdx@yahoo.com
 
JAKSBT Medical CO. Ltd.
(Central China-exclusive in Hunan, Hubei and Henan)
Email: jaksbt@sina.com
 
Apex Medical Co., Ltd.
(Southwest China-exclusive in Sichuan, Chongqing, Yunnan and Guizhou)
Email: apexmed.xu@gmail.com
 
Science International Corporation (HK and Macau)
Tel: +852 2543 7442
Fax: +852 2541 4089
Email: stephenchiu@scienceintel.com
 
Tianjin YiMei Science Co., Ltd. (Industrial/Life Science)
Tel:
Email: yimei@yimeisci.com 
Web: http://www.yimeisci.com

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.